Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
Azemiglitazone (2 trials)
Diabetes Mellitus (Phase 3)
Fatty Liver (Phase 3)
Liver Diseases (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 3)
Trials (2 total)
Trial APIs (1 total)